CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 13 of 48

Rheumatology (Oxford)

Briefs 481–520 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Ten-year cardiovascular risk changes and major adverse events in gout patients

    Cohort studyGout & crystals

  2. Rheumatology (Oxford)

    Efficacy and safety of a millimetre wave medical device for pain neuromodulation in peripheral OA: a crossover randomized trial

    Randomized controlled trialOsteoarthritis

  3. Rheumatology (Oxford)

    Inflammation assessment in psoriatic arthritis via optical spectral transmission: correlations with clinical markers and musculoskeletal ultrasound

    Diagnostic or prognostic studySpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    Is antimalarial use associated with a reduced risk of LN in patients with SLE? Results from an inception cohort-based study

    Cohort studyLupus & APS

  5. Rheumatology (Oxford)

    Sustained cardiovascular risk factor control is associated with reduced metabolic dysfunction-associated steatotic liver disease risk in SLE

    Cross-sectional studyLupus & APS

  6. Rheumatology (Oxford)

    Global burden of osteoarthritis in middle-aged adults (40–59 years): estimates from the Global Burden of Disease 2021 study

    Secondary analysisOsteoarthritis

  7. Rheumatology (Oxford)

    Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative study

    Research articleSystemic sclerosis

  8. Rheumatology (Oxford)

    A new characteristic of SLE: subclinical vein involvement–an in-depth biochemical and imaging study

    Cross-sectional studyLupus & APS

  9. Rheumatology (Oxford)

    Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry

    Cross-sectional studySystemic sclerosis

  10. Rheumatology (Oxford)

    Risk prediction model for relapse of anti-synthetase syndrome-associated interstitial lung disease in Japanese multicentre MYKO cohort study

    Cohort studyMyositis

  11. Rheumatology (Oxford)

    Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease

    Cross-sectional studySpondyloarthritis & PsA

  12. Rheumatology (Oxford)

    Venous thromboembolism in patients with lupus nephritis: frequency and risk factors—a cohort study

    Cohort studyLupus & APS

  13. Rheumatology (Oxford)

    Arterial stiffness in different age and cardiovascular risk groups of patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  14. Rheumatology (Oxford)

    Transorbital ultrasonography reveals persistent decrease in retinal artery flow and optic nerve diameter in treated giant cell arteritis

    Cohort studyVasculitis & PMR

  15. Rheumatology (Oxford)

    Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation

    Secondary analysisVasculitis & PMR

  16. Rheumatology (Oxford)

    RA and risk of colorectal cancer: a nationwide cohort study

    Cohort studyRA

  17. Rheumatology (Oxford)

    Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study

    Secondary analysisSpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    The Michael Mason prize: development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine

    Research articleOsteoporosis

  19. Rheumatology (Oxford)

    High risk of bloodstream infections, diverse causal pathogens and association with haemodialysis and plasma exchange in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  20. Rheumatology (Oxford)

    Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers

    Cross-sectional studyMyositis

  21. Rheumatology (Oxford)

    Impaired humoral and T helper cell responses to toxic shock syndrome toxin-1 (TSST-1) in granulomatosis with polyangiitis

    Mechanistic studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis

    Cohort studySpondyloarthritis & PsA

  23. Rheumatology (Oxford)

    Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases

    Cohort studyVasculitis & PMR

  24. Rheumatology (Oxford)

    Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy response

    Cohort studyLupus & APS

  25. Rheumatology (Oxford)

    A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score

    Diagnostic or prognostic studySystemic sclerosis

  26. Rheumatology (Oxford)

    Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study

    Cohort studyVasculitis & PMR

  27. Rheumatology (Oxford)

    How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort

    Cohort studyPediatric

  28. Rheumatology (Oxford)

    Anxiety symptoms and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a cross-sectional study

    Cross-sectional studySystemic sclerosis

  29. Rheumatology (Oxford)

    Phenotypic clusters of long-term damage in Sjögren’s disease: a 15-year multicentre study

    Cohort studySjögren's & overlap

  30. Rheumatology (Oxford)

    Eye-openers for advanced management of elderly-onset rheumatoid arthritis

    Secondary analysisRA

  31. Rheumatology (Oxford)

    Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis

    Cohort studySystemic sclerosis

  32. Rheumatology (Oxford)

    Exploration of health-related quality of life, anxiety and depression in antineutrophil cytoplasmic antibody-associated vasculitis

    Cross-sectional studyVasculitis & PMR

  33. Rheumatology (Oxford)

    Associations between dietary mineral intake and rheumatoid arthritis: evidence from UK Biobank and NHANES

    Cohort studyRA

  34. Rheumatology (Oxford)

    Self-reported cognitive dysfunction and memory impairment in Systemic Autoimmune Rheumatic Diseases (SARDs): a mixed methods analysis of the INSPIRE cohort

    Cohort studyAcross diseases

  35. Rheumatology (Oxford)

    Risk of venous thromboembolism in people with RA: a population-based study in the UK

    Cohort studyRA

  36. Rheumatology (Oxford)

    Crosstalk between macrophages and fibroblasts contributes to inflammation and damage in giant cell arteritis

    Mechanistic studyVasculitis & PMR

  37. Rheumatology (Oxford)

    Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry

    Cohort studySystemic sclerosis

  38. Rheumatology (Oxford)

    Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region

    Mechanistic studyMyositis

  39. Rheumatology (Oxford)

    Prevalence and functional characterization of anti-interferon autoantibodies in inflammatory myopathies

    Cross-sectional studyMyositis

  40. Rheumatology (Oxford)

    Assessing the content validity of a Patient Reported Outcome Measure item pool for Rheumatoid Arthritis Disease Activity using cognitive interviews

    Research articleRA

All 1,905 Briefs in ExploreShowing Briefs 481–520 of 1,905, newest first